Placebo to match sofosbuvir

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Hepatitis C VirusHepatitis C, Chronic

Phase 2

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

CompletedNCT01188772

Gilead SciencesHepatitis C Virus

Start: 2010-08-31End: 2012-05-31Updated: 2014-04-21

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

CompletedNCT01435044

Gilead SciencesHepatitis C, Chronic

Start: 2011-09-30End: 2013-05-31Updated: 2014-02-06

Related Papers

Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis.

2022-06-083 citations

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.

2013-03-15226 citations